Publications database

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: Brain research throws light on addiction; European action on drugs; Associations between...

This report provides a comprehensive review of the relatively new phenomenon of Internet-based drug treatment interventions (DTI). It presents a sample of Internet-based DTI programmes across Europe and outlines their methodologies, providing...

This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances...

This work programme ensures that the EMCDDA remains a key resource for Europe — providing high-quality information to underpin effective drug policies and serving as a catalyst for supporting and developing national...

This report reviews developments in the neuroscience of addiction, explores how they might affect the way we view and treat drug problems, and considers the issues that they raise for drug policy...

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. Published every spring, it catalogues the Centre’s achievements in each...

This briefing paper for policymakers presents how new discoveries in neurobiology have the potential to transform our perception of drug addiction and its treatment, whilst also considering the ethical issues such treatment...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: 15 years of drug monitoring in Europe; new European study on Internet-based...

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2008. In 2008, 13 new psychoactive substances were officially notified...

Epidemiological studies routinely collect quantitative data on gender differences in drug use (e.g. prevalence, mortality), but far less is published on the qualitative aspects of female drug problems. This review presents quotations...